23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ME | AZN | AMGN | GILD | BMY |
| Company | 23Andme Holding Co. | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.7480 | 183.01 | 331.95 | 135.00 | 56.01 |
| High | 1.1000 | 185.82 | 338.49 | 137.50 | 57.02 |
| Low | 0.6000 | 182.70 | 329.80 | 132.71 | 55.45 |
| Latest | 0.6063 | 184.54 | 336.29 | 134.94 | 56.45 |
| Change | -0.1637 | +2.68 | +6.70 | +1.42 | +0.78 |
| % Change | -21.26% | +1.47% | +2.03% | +1.06% | +1.40% |
| Volume | 29,751,400 | 1,595,982 | 3,118,400 | 6,033,600 | 9,274,133 |
| 20-Day Average Volume | 11,485,064 | 2,080,730 | 2,688,405 | 6,066,655 | 10,248,860 |
| Previous Close | 0.7700 | 181.86 | 329.59 | 133.52 | 55.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4246 | 189.63 | 339.60 | 133.34 | 58.00 |
| 20-Day Raw Stochastic | 4.95% | 17.94% | 43.35% | 54.80% | 19.44% |
| 20-Day Relative Strength | 27.35 | 42.59 | 45.31 | 48.51 | 44.26 |
| Weighted Alpha | -83.66 | +27.12 | +18.85 | +26.75 | +20.38 |
| Today's Opinion | 100% Sell | 8% Sell | 8% Sell | 24% Buy | 24% Buy |
| Previous Opinion | 100% Sell | 8% Sell | 8% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 40% Buy | 40% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -66.13% since 03/21/25 | +1.82% since 05/05/26 | +2.03% since 05/05/26 | +1.09% since 05/05/26 | -0.88% since 05/05/26 |
| Low | 0.5300 on 03/26/25 | 181.03 on 05/07/26 | 327.22 on 05/07/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 1.3700 on 03/27/25 | 185.82 on 05/12/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.40 on 05/06/26 |
| 1-Month | |||||
| %Chg | -72.44% since 02/28/25 | -9.55% since 04/10/26 | -4.20% since 04/10/26 | -2.91% since 04/10/26 | -3.70% since 04/10/26 |
| Low | 0.5300 on 03/26/25 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 2.0700 on 03/17/25 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -81.63% since 12/27/24 | -9.77% since 02/12/26 | -8.17% since 02/12/26 | -11.11% since 02/12/26 | -5.70% since 02/12/26 |
| Low | 0.5300 on 03/26/25 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 4.1800 on 01/08/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -89.69% since 09/27/24 | +5.23% since 11/12/25 | unch since 11/12/25 | +9.35% since 11/12/25 | +15.02% since 11/12/25 |
| Low | 0.5300 on 03/26/25 | 175.24 on 11/13/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 7.8800 on 10/02/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,265 | 282,048,128 | 177,874,784 | 165,774,416 | 113,682,088 |
| Shares Outstanding, K | 26,827 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 219,640,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -666,700,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 60,260,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -53,040,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.19 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.02 on 01/28/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/22/25 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.75 | 15.01 | 15.69 | 9.47 |